6-K
 

 
 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

For February 24, 2005

EXTENDICARE INC.

(Translation of registrant’s name into English)

3000 Steeles Avenue East
Markham, Ontario, Canada L3R 9W2
(Address of principal executive offices)

     Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

     
Form 20-F o   Form 40-F þ

     Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

     
Yes o   No þ

          If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A

 
 

 

 

TABLE OF CONTENTS

EXHIBIT INDEX
SIGNATURES

EXHIBIT INDEX

     
Exhibit
Number
  Description of Exhibit
99.1
  News Release dated February 22, 2005 – Extendicare Inc. Delivers Record EPS of $1.78 in 2004 and Initiates Common Share Dividend

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

         
  EXTENDICARE INC.
 		  
Date: February 24, 2005  By:   /s/ RICHARD L. BERTRAND    
    Richard L. Bertrand   
    Senior Vice-President and Chief Financial Officer